Night-Shift workers test gut bug and herb combo to beat diabetes risk

NCT ID NCT07440147

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study tests whether taking a combination of Akkermansia muciniphila (a beneficial gut bacterium) and berberine (a plant compound) can improve insulin sensitivity in night-shift workers. 200 participants from healthcare and industry in Austria and Denmark will receive either the supplements or a placebo for 12 weeks, then switch after a break. The main goal is to see if this approach lowers insulin resistance, a key risk factor for type 2 diabetes.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
Akkermansia muciniphila (a gut bacterium) and berberine (a plant compound) taken as dietary supplements
What this could lead to
If it works, this could point toward a simple supplement combination to help night-shift workers improve insulin sensitivity and reduce their risk of type 2 diabetes.
What could go wrong
This is an early-stage trial with no phase designation, and the supplements may not improve insulin sensitivity more than placebo. Results may not apply to non-shift workers or other populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CIRCADIAN RHYTHM DISORDERS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • FH JOANNEUM University of Applied Sciences

    RECRUITING

    Graz, Styria, 8020, Austria

More trials for these conditions

Other studies related to the condition(s) this trial covers.